About News desk

This author has not yet filled in any details.
So far News desk has created 2504 blog entries.

Scientists unlock secrets of mutation of molecular anchor that can lead to ALS

Researchers have shed new light on the causes of ALS through an investigation of a molecular anchor called VAP (vesicle-associated membrane protein-associated protein).

When experiencing new things, the structure and function of our neurons and their connections are rapidly being remodeled. This process, known as synaptic plasticity, is critical for us to learn and adapt. However, these changes require a lot of energy. Fortunately, our neurons are well-adapted to support these changes. Biological batteries known as mitochondria are strategically stabilized near sites of synaptic remodeling to ensure a local and efficient energy supply. However, how mitochondria are anchored near synapses was not known. A team of scientists at Max Planck Florida Institute for Neuroscience has now identified a molecular anchor called VAP that stabilises mitochondria near synapses to support these remodeling projects. The identification of VAP as a molecular anchor has particular significance because a mutation in VAP leads to ALS (amyotrophic lateral sclerosis), a progressive motor neuroe degeneration disease. This discovery, published in Nature Communications, not only sheds light on how memories are powered but opens up new research directions into ALS pathology.
By |2024-07-04T17:28:54+01:008 January 2024|News, MND / ALS, Research|

Milestone in exoskeleton’s US healthcare journey

News this week from the US health insurance world has provided encouragement for those pushing to increase access to rehab-based exoskeletons.

For the first time, Medicare, the US federal health insurance programme, has made a payment to rehab tech developer ReWalk for its wearable robotic device that allows paraplegics to walk again. The ReWalk Personal Exoskeleton enables powered hip and knee motion for people with a spinal cord injury (SCI), allowing them to stand upright, walk, turn, and climb up and down stairs. According to reports, the payment of US$94,617 to ReWalk was made via Medicare administrative contractor Noridian Healthcare Solutions. It could be a sign that the news represents recognition of exoskeletons as medically necessary for people with an SCI.
By |2024-07-04T17:28:54+01:008 January 2024|Tech & industry, Spinal injury|

A new tool in the fight to save brain injured babies

The development of a device which harnesses AI to detect brain injuries in newborn babies is speeding up thanks to a funding boost.

NeuroBell, an Irish university spinout has developed technology that enables real-time, accurate detection of seizures in newborn babies needing additional care. It uses artificial intelligence (AI) to help clinicians diagnose abnormal brain activity faster, enabling early intervention that can improve outcomes. NeuroBell was founded by Dr Mark O’Sullivan, Dr Alison O’Shea and Colm Murphy, and is a spin-out from University College Cork and the Irish Centre for Maternal and Child Health Research (Infant). It aims to address what the founders see as a critical gap in the availability and accuracy of current technologies used to detect seizures in newborns admitted to the neonatal intensive care unit (NICU).
By |2024-07-04T17:28:54+01:008 January 2024|Brain injury|

Brain injury markers missed – COVID study

Markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal, a new study has revealed. The reseach COVID-19 Clinical Neuroscience Study (COVID-CNS) was led by the University of Liverpool and King’s College London, with support from scientists from the ISARIC4C consortium, The Pandemic Institute and the NIHR BioResource. Professor Benedict Michael is Principal Investigator and Director of the University of Liverpool’s Infection Neuroscience Laboratory and Honorary Consultant Neurologist, The Walton Centre NHS Foundation Trust. The researcher said: “During the COVID-19 pandemic it became apparent that neurological complications were occurring in a significant proportion of hospitalised patients and even in those with mild COVID-19 infection.

By |2024-07-04T17:28:55+01:002 January 2024|Brain injury|

Families urged to ‘know their rights’ as DHSC publishes new CHC guidance

The new guidelines enable Integrated Care Boards (ICBs) to consider eligibility for a past period of NHS continuing healthcare (CHC), even for those who did not apply, but think they are entitled to funding.

By |2024-07-04T17:28:56+01:0021 December 2023|News, Parkinson's|
Go to Top